CME Group Inc (CME) Shares Bought by Raymond James Trust N.A.

Raymond James Trust N.A. raised its stake in CME Group Inc (NASDAQ:CME) by 3.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,460 shares of the financial services provider’s stock after buying an additional 605 shares during the period. Raymond James Trust N.A.’s holdings in CME Group were worth $3,142,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CME. Janus Henderson Group PLC increased its stake in shares of CME Group by 13.2% during the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after purchasing an additional 716,655 shares in the last quarter. Renaissance Technologies LLC purchased a new position in shares of CME Group during the 2nd quarter worth approximately $96,350,000. Unigestion Holding SA purchased a new position in shares of CME Group during the 2nd quarter worth approximately $96,251,000. KAMES CAPITAL plc purchased a new position in shares of CME Group during the 2nd quarter worth approximately $85,187,000. Finally, Standard Life Aberdeen plc increased its stake in shares of CME Group by 38.1% during the 2nd quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock worth $289,472,000 after purchasing an additional 487,442 shares in the last quarter. 84.03% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently weighed in on CME shares. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 3rd. Jefferies Financial Group raised their price objective on shares of CME Group to $203.00 and gave the stock a “buy” rating in a research note on Monday, October 8th. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 9th. Rosenblatt Securities began coverage on shares of CME Group in a research note on Wednesday, September 5th. They set a “neutral” rating and a $177.00 price objective for the company. Finally, Compass Point began coverage on shares of CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 target price on the stock. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $181.38.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Thursday, October 11th. The shares were sold at an average price of $179.86, for a total value of $449,650.00. Following the transaction, the chief financial officer now owns 32,720 shares in the company, valued at approximately $5,885,019.20. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Bryan T. Durkin sold 11,509 shares of CME Group stock in a transaction on Monday, August 6th. The shares were sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the completion of the transaction, the president now owns 64,862 shares in the company, valued at approximately $10,508,292.62. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,188 shares of company stock worth $4,973,607. 0.43% of the stock is owned by company insiders.

Shares of NASDAQ CME opened at $178.06 on Wednesday. CME Group Inc has a 1 year low of $132.33 and a 1 year high of $182.97. The company has a market cap of $57.79 billion, a P/E ratio of 37.33, a PEG ratio of 3.20 and a beta of 0.64. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, July 26th. The financial services provider reported $1.74 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.02. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the business earned $1.22 earnings per share. CME Group’s revenue was up 14.6% compared to the same quarter last year. Sell-side analysts anticipate that CME Group Inc will post 6.64 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 25th. Investors of record on Monday, September 10th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Friday, September 7th. This represents a $2.80 dividend on an annualized basis and a yield of 1.57%. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: What are retained earnings?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply